DISQO announces AI Search Lift!

Read about it in Adweek

or get product details →

Learn more×

Case Study

•

June 25, 2026

•

5

min read

Brand and Outcomes Lift for a Fortune Global 500 pharmaceutical brand

How a Fortune Global 500 pharmaceutical brand used DISQO Brand Lift and Outcomes Lift to beat DISQO benchmarks and shorten optimization from quarters to weeks.

Industry

Healthcare & Pharma

Engagement

Brand

Product type

Brand Lift, Outcomes Lift
Brand and Outcomes Lift for a Fortune Global 500 pharmaceutical brand
Accelerating campaign performance by optimizing for high-impact audiences early

Accelerating campaign performance by optimizing for high-impact audiences early

A leading global pharmaceutical brand connected verified ad exposure across paid social, display, endemic publishers, and CTV to shifts in brand perception and digital behavior.

3.4x
The DISQO benchmark for aided awareness lift (+3 pts)
+4 pts
Lift in brand-specific intent, 1.7x the DISQO benchmark
~80%
Stronger intent lift vs. the mid-campaign read

Overview

A leading global pharmaceutical brand set out to strengthen its position in a highly competitive category across various product lines. With investment spanning social media, endemic publishers, digital, and connected television, the brand’s objective was to drive meaningful shifts in awareness, favorability, and consideration while also influencing lower-funnel behaviors.

This required understanding how creative, channel mix, audience targeting, and frequency worked together to shape perception and drive action. The brand also needed defensible proof and deeper insights about which media investments were driving incremental brand movement and behavioral engagement, rather than simply generating impressions or surface-level engagement.

To elevate its measurement strategy, the organization partnered with DISQO, introducing cross-platform Brand Lift and Outcomes Lift measurement into its analytics stack to enable faster optimization and more confident decision-making across teams.

Challenge

Proving persuasion where conversions can’t be seen

Pharmaceutical marketers operate within a fundamentally different performance environment than most other industries. Direct transactions aren’t measurable in traditional digital terms. Prescription decisions unfold across physician consultations, insurance approvals, and extended patient timelines. There are no add-to-cart events tied to campaign exposure, and research behavior typically occurs in environments that pharma manufacturers cannot see.

As a result, intent signals such as impressions, clicks, and conversions often fail to capture the full scope of impact. Without a unified, exposure-based system capable of connecting media delivery to brand and behavioral outcomes during active campaigns, the brand faced critical unanswered questions.

Platform metrics provide engagement data but fail to demonstrate persuasion. Platform studies operate within closed ecosystems and lack independent validation. Behavioral correlation partners provide useful diagnostics on prescription patterns and audience quality, yet they do not deliver a comprehensive cross-channel performance view. Performance conversations defaulted to surface-level efficiency metrics, while strategic decisions waited months for marketing mix confirmation.

The brand needed a deterministic framework that could unify inputs and enable faster, more confident decision-making to:

  • Isolate the impact of campaign exposure across channels
  • Measure both attitudinal and behavioral movement
  • Validate or challenge platform-reported results
  • Identify messaging or audience weaknesses before sales data confirmed them
  • Shorten the optimization cycle from quarters to weeks

Solution

Cross-platform Brand Lift and Outcomes Lift

The brand partnered with DISQO to implement cross-platform Brand Lift and Outcomes Lift measurement, enabling them to quantify the incremental, person-level impact of their media investments.

Rather than relying on modeled assumptions or platform-reported exposure, DISQO connected verified ad exposure across paid social, digital display, endemic publishers, and connected television to measurable shifts in brand perception and digital behaviors.

DISQO measurement framework: Brand Lift metrics and Outcomes Lift metrics

This unified approach created a triangulation layer within the brand’s broader measurement ecosystem. DISQO data sat alongside marketing mix modeling, claims-based prescription correlation analysis, traditional market research, and platform studies, providing an independent source of truth during the campaign lifecycle. When DISQO’s findings aligned with platform studies and behavioral diagnostics, the brand moved quickly to scale investment. When discrepancies surfaced, deeper analysis followed.

Most importantly, DISQO shortened the feedback loop. Instead of waiting eight to twelve months for market mix results, the brand could evaluate the impact within weeks of launch, refining creative, channel allocation, and messaging while campaigns were still active. Measurement shifted from retrospective validation to strategic acceleration.

Impact

Statistically significant gains across the funnel

The campaign delivered statistically significant gains across awareness, intent, and behavioral outcomes, exceeding DISQO norms in key performance areas and accelerating mid-funnel demand in a highly regulated category.

Bar chart: aided awareness +3 pts (3.4x benchmark), familiarity +3 pts (1.2x), consideration +3 pts (1.3x), brand-specific intent +4 pts (1.7x)

Upper-funnel brand awareness

  • Aided awareness saw a +3 point lift, outperforming the DISQO benchmark by 3.4x.
  • Familiarity increased by +3 points, outperforming the DISQO benchmark by 1.2x.
  • Among key audiences, lift was substantially stronger: up to +9 points of perception lift within priority segments, with consistent statistically significant gains among high-value age cohorts.

With one specific key audience, awareness increased following exposure. However, because baseline awareness in the control group was so low, the exposed group’s significant lift revealed a critical segmentation insight: this audience lacked foundational category understanding. The brand refined its strategy to prioritize category education for this high-value segment before brand differentiation messaging.

Mid-funnel intent and consideration

  • Consideration increased by +3 points, outperforming DISQO norms by 1.3x.
  • Brand-specific intent increased by +4 points, delivering 1.7x the DISQO benchmark.
  • Intent lift improved nearly 80% vs. the mid-campaign read, signaling sustained exposure impact.

Behavioral acceleration

  • Branded online search rose by +0.18%.
  • Branded site visitation rose by +0.10%.

Driving tactics

By aligning high-impact placements and optimizing frequency using deterministic measurement, the campaign:

  • Identified breakthrough performance among priority audience segments
  • Validated specific channel environments as top intent drivers
  • Confirmed the exposure sweet spot as the optimal frequency range for perception and intent lift
  • Accelerated mid-flight optimization in a category where direct conversions cannot be observed

Key takeaways

Optimize frequency to maximize lift

Exposure strategy must be intentional and performance-informed. More impressions do not automatically translate to greater impact. In healthcare advertising, lift strengthens when frequency is calibrated against incremental brand and intent movement rather than scaled indiscriminately.

Prioritize comparative performance

In regulated categories where conversions cannot be directly observed, benchmarks provide context, but comparative performance drives real insight. Understanding how tactics perform relative to one another reveals which channels and strategies truly drive outcomes, even when several exceed benchmarks.

Measure behavior beyond owned platforms

Attitudinal lift is most powerful when paired with behavioral evidence. Deterministic measurement of off-site search and site engagement provides tangible proof that advertising is moving consumers closer to consultation and treatment consideration.

Discover why. Let’s DISQO: hello@disqo.com

Quote

“DISQO has become a trusted partner for our team. Their measurement gives us clear visibility into how our campaigns are performing across brand and behavioral outcomes. We have greater confidence in our media investments and stronger alignment across teams because we are working from the same set of evidence. The insights help us make faster decisions and continuously improve performance.”

Sr. Director, Digital Analytics
Fortune Global 500 pharmaceutical brand

Learn more

Industry insights

Ready to see what others can't? Speak with an expert.